However, SIT treatment significantly reduced the expression of JNK1, IKKβ and NF-κB in type-2 diabetic rats, which in turn is suggestive of its potential to attenuate obesity induced inflammation and insulin resistance. Here, IKBKB is linked to Insulin resistance.